HFS
VNDA icon

Hughes Financial Services’s Vanda Pharmaceuticals VNDA Stock Holding History

Hughes Financial Services’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6 Hold
1
– – ﹤0.01% 1834
2026
Q1 		$7 Buy
+1
New +$8 ﹤0.01% 1705
2025
Q3 		– Sell
-121
Closed -$511 – 1112
2025
Q2 		$511 Buy
+121
New +$529 ﹤0.01% 955

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hughes Financial Services's VNDA Position: Q2 2026 in Review

Hughes Financial Services held its Vanda Pharmaceuticals (VNDA) position steady in Q2 2026 at 1 share worth $6. The position accounts for ﹤0.01% of the portfolio, ranked #1834.

Hughes Financial Services first reported a position in VNDA in Q2 2025 and has held it in 3 quarters since. The position peaked at $511 in Q2 2025. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Hughes Financial Services held 1 share of Vanda Pharmaceuticals worth $6 as of Q2 2026.
  • Hughes Financial Services left its Vanda Pharmaceuticals share count unchanged in Q2 2026.
  • Vanda Pharmaceuticals made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #1834 holding.
  • Hughes Financial Services first reported a position in Vanda Pharmaceuticals in Q2 2025 and has held it in 3 quarters since.
  • Hughes Financial Services's Vanda Pharmaceuticals position peaked at $511 in Q2 2025.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.